On February 17, 2020 Celyad (Euronext Brussels and Paris, and Nasdaq: CYAD), a clinical-stage biopharmaceutical company focused on the development of CAR-T cell-based therapies, reported that the company plans to participate at the following conferences in February and March 2020 (Press release, Celyad, FEB 17, 2020, View Source [SID1234554397]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

9th Annual SVB Leerink Global Healthcare Conference
Date: Tuesday, February 25, 2020
Presentation time:3:30 p.m. ET
Location: New York, New York
Webcast: A live and archived webcast of the presentation will be available in the Events & Webcasts section of the Celyad website

3rd Annual CAR-TCR Summit Europe
Date: Wednesday, February 26, 2020
Time: 12:30 p.m. GMT
Location: London, United Kingdom

27th International Molecular Med Tri-Conference
Date: Wednesday, March 4, 2020
Presentation Time:2:35 p.m. PT
Location: San Francisco, California

Cambridge Healthtech Institute’s 5th Annual Immuno-Oncology Summit Europe 2020
Date: Wednesday, March 11, 2020
Presentation time: 9:05 a.m. GMT
Location: London, United Kingdom

BioCapital Europe 2020
Date: Thursday, March 12, 2020
Presentation time: 3:50 p.m. CET
Location: Amsterdam, Netherlands

VFB Congress Happening
Date: Saturday, March 28, 2020
Presentation time: 1:40 p.m. CET
Location: Antwerp, Belgium